Your Article Summary
A quick guide to EU's new pharmacovigilance package: what pharma companies should do
PharmExec, 07/30/09
Over the last couple of decades, advances in biomedical science have generated more new and complex medicines to treat a broader range of diseases and conditions than ever before. The number of people taking medications has increased dramatically, and, as a result, governments, patient groups and health advocates are demanding stronger regulatory practices and procedures, to assure the safety of medicines before and after they reach the market.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
Medtronic Introduces 3D Recon Service to Enhance Endovascular Treatment of Aortic Aneurysms
Medtronic, 11/20/09
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
A look at how far hospitals have come since To Err is Human report
American Hospital Association News, 11/25/09
AstraZeneca and the Philadelphia Department of Public Health provide free medicines to Pennsylvanias uninsured
AstraZeneca, 11/24/09
Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
Amgen, 11/24/09
Article Search
Sponsor


See Latest Articles


